Elements Vital to Treat Obesity Study
EVO
Evaluating the EVO Treatment Optimized for Resource Constraints: Elements Vital to Treat Obesity.
1 other identifier
interventional
524
1 country
1
Brief Summary
The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Mar 2021
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2021
CompletedFirst Posted
Study publicly available on registry
January 14, 2021
CompletedStudy Start
First participant enrolled
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2026
ExpectedMay 6, 2026
April 1, 2026
4.8 years
January 12, 2021
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight
Participant change in weight, in kilograms, from baseline to 6-months.
Baseline to 6-Months
Secondary Outcomes (1)
Costs of treatment
12 Months
Study Arms (2)
Smartphone App Participants (APP)
EXPERIMENTALSmartphone application, diet and activity goals, online lessons, brief remote sessions with a Health Promotionist
Diabetes Prevention Program Participants (DPP)
EXPERIMENTALParticipant program manual, diet and activity logs, hour long remote sessions with a Health Promotionist
Interventions
Participants will receive calorie, fat, and physical activity goals, a Smartphone application for self-monitoring their diet, activity and weight, online educational readings, and brief bi-weekly remote health sessions with a Health Promotionist. They will also be provided with a wireless bluetooth scale and portable blood pressure machine.
In accordance with the Center for Disease Control curriculum, participants will receive a participant log for tracking physical activity, food intake, and weight, a paper participant guide with worksheets, logs, and psycho-educational materials, and 16 hour long remote sessions with a Health Promotionist. They will also be provided with a wireless bluetooth scale and portable blood pressure machine.
Eligibility Criteria
You may qualify if:
- BMI 30-45
- Weight stable
- Own a Smartphone and be willing to install our Smartphone app
- Willing to conduct video conference calls with study staff
You may not qualify if:
- Enrolled in any formal weight loss program
- Taking anti-obesity medications
- Not taking medications that may cause weight gain
- Unstable medical conditions
- Diabetes requiring insulin supplementation
- Crohn's Disease
- Diagnosis of obstructive sleep apnea requiring intervention (i.e., CPAP)
- Assistive devices for mobility
- Hospitalizations for a psychiatric disorder within the past 5 years
- Cardiovascular disease symptoms while performing moderate intensity exercise
- Pregnancy, trying to get pregnant, or lactating.
- Bulimia or binge eating disorder
- Reports of active suicidal ideation
- Current substance abuse or dependence besides nicotine dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Washington University School of Medicinecollaborator
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
Related Publications (1)
Metzendorf MI, Wieland LS, Richter B. Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity. Cochrane Database Syst Rev. 2024 Feb 20;2(2):CD013591. doi: 10.1002/14651858.CD013591.pub2.
PMID: 38375882DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Pfammatter, PhD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 12, 2021
First Posted
January 14, 2021
Study Start
March 16, 2021
Primary Completion
December 15, 2025
Study Completion (Estimated)
July 10, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share